James D. Stewart

James D. Stewart

Auto-generated profile, based on publicly available information

James D. Stewart

Department of Medicine, Cairns Hospital , Cairns, Queensland

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2017 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
JSJames D. Stewart
James D. Stewart
SSSimon Smith
Simon Smith
EBEnzo Binotto
Enzo Binotto
John McBrideJohn McBride
John McBride
BCBart J. Currie
Bart J. Currie
JHJosh Hanson
Josh Hanson
The epidemiology, clinical presentation and management of melioidosis vary around the world. It is essential to define the disease’s local features to optimise its management. Between 1998 and 2016 there were 197 cases of culture confirmed melioidosis in Far North Queensland; 154 (78%) presented in the December-April wet season. 145 (74%) patients were bacteraemic, 58 (29%) were admitted to the Intensive Care Unit and 27 (14%) died; nine (33%) of these deaths occurred within 48 hours of presentation. Pneumonia was the most frequent clinical finding, present in 101 (61%) of the 166 with available imaging. A recognised risk factor for melioidosis (diabetes, hazardous alcohol use, chronic renal disease, chronic lung disease, immunosuppression or malignancy) was present in 148 (91%) of 162 patients with complete comorbidity data. Despite representing only 9% of the region’s population, Aboriginal and Torres Strait Island (ATSI) people comprised 59% of the cases. ATSI patients were younger than non-ATSI patients (median (interquartile range): 46 (38–56) years versus 59 (43–69) years (p<0.001) and had a higher case-fatality rate (22/117 (19%) versus 5/80 (6.3%) (p = 0.01)). In the 155 patients surviving the initial intensive intravenous phase of treatment, eleven (7.1%) had disease recurrence, despite the fact that nine (82%) of these patients had received prolonged intravenous therapy. Recurrence was usually due to inadequate source control or poor adherence to oral eradication therapy. The case fatality rate declined from 12/44 (27%) in the first five years of the study to 7/76 (9%) in the last five (p = 0.009), reflecting national improvements in sepsis management. Melioidosis in Far North Queensland is a seasonal, opportunistic infection of patients with specific comorbidities. The ATSI population bear the greatest burden of disease. Although the case-fatality rate is declining, deaths frequently occur early after hospitalisation, reinforcing the importance of prompt, targeted therapy in high-risk patients. Burkholderia pseudomallei is endemic to the tropics and is responsible for the disease melioidosis. Exposure rarely evolves to significant disease in the absence of specific comorbidities. Conversely, in susceptible hosts, the disease can be rapidly fatal if unrecognised. Patients require an extended course of intravenous and oral antibiotic therapy to treat the disease and to prevent its recurrence. This retrospective, case series describes the epidemiology, presentation and outcomes of 197 cases of melioidosis in Far North Queensland (FNQ), Australia. The study confirms that melioidosis is predominantly a seasonal, opportunistic infection occurring among patients with specific comorbidities that include diabetes mellitus, hazardous alcohol use, chronic kidney disease, chronic lung disease, malignancy and immunosuppressive therapy. Melioidosis is more common in the local Aboriginal and Torres Strait Islander (ATSI) population, which has a higher prevalence of these comorbidities. Although overall case-fatality rates are declining, they are higher in the ATSI population, reflecting ongoing socioeconomic disadvantage. Disease recurrence is more likely in patients with inadequate source control and suboptimal adherence, factors that are not necessarily mitigated by extending the duration of intravenous therapy.

1 March 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ADAntony J. Davis
Antony J. Davis
MPMatthew A. Perugini
Matthew A. Perugini
BSBrian J. Smith
Brian J. Smith
JSJames D. Stewart
James D. Stewart
TIThomas Ilg
Thomas Ilg
EHEmanuela Handman
Emanuela Handman
Leishmania parasites synthesize a range of mannose-containing glycoconjugates thought to be essential for virulence in the mammalian host and sandfly vector. A prerequisite for the synthesis of these molecules is the availability of the activated mannose donor, GDP-Man, the product of the catalysis of mannose-1-phosphate and GTP by GDP-mannose pyrophosphorylase (GDP-MP). In contrast to the lethal phenotype in fungi, the deletion of the gene in Leishmania mexicana did not affect parasite viability but led to a total loss of virulence, making GDP-MP an ideal target for anti-Leishmania drug development. We show by immunofluorescence and subcellular fractionation that GDP-MP is a cytoplasmic protein, and we describe a colorimetric activity assay suitable for the high throughput screening of small molecule inhibitors. We expressed recombinant GDP-MP as a fusion with maltose-binding protein and separated the enzyme from maltose-binding protein by thrombin cleavage, ion-exchange, and size exclusion chromatography. Size exclusion chromatography and analytical ultracentrifugation studies demonstrate that GDP-MP self-associates to form an enzymatically active and stable hexamer. However, sedimentation studies show that the GDP-MP hexamer dissociates to trimers and monomers in a time-dependent manner, at low protein concentrations, at low ionic strength, and at alkaline pH. Circular dichroism spectroscopy reveals that GDP-MP is comprised of mixed α/β structure, similar to its closest related homologue, N-acetyl-glucoseamine-1-phosphate uridyltransferase (Glmu) from Streptococcus pneumoniae. Our studies provide insight into the structure of a novel target for the development of anti-Leishmania drugs.

1 January 2008 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
Victoria LawsonVictoria Lawson
Victoria Lawson
LVLaura Vella
Laura Vella
JSJames D. Stewart
James D. Stewart
RSRobyn A. Sharples
Robyn A. Sharples
HKHelen Klemm
Helen Klemm
AHAndrew Hill
Andrew Hill

31 July 2005 in International Journal for Parasitology
Verified
Journal Article
Closed access
JSJames Stewart
James Stewart
JCJoan Curtis
Joan Curtis
TSTimothy P. Spurck
Timothy P. Spurck
TIThomas Ilg
Thomas Ilg
AGAttila Garami
Attila Garami
EHEmanuela Handman
Emanuela Handman

1 October 2007 in Journal of General Virology
Verified
Journal Article
Open access
Victoria LawsonVictoria Lawson
Victoria Lawson
JSJames D. Stewart
James D. Stewart
CMColin L. Masters
Colin L. Masters
The unconventional nature of the infectious agent of prion diseases poses a challenge to conventional infection control methodologies. The extraneural tissue distribution of variant and sporadic Creutzfeldt–Jakob disease has increased concern regarding the risk of prion disease transmission via general surgical procedures and highlighted the need for decontamination procedures that can be incorporated into routine processing. In this study, the ability of preparations of enzymatic medical instrument cleaners to reduce the infectivity associated with a rodent-adapted strain of human prion disease, previously reported to be resistant to decontamination, was tested. Efficient degradation of the disease-associated prion protein by enzymatic cleaning preparations required high treatment temperatures (50–60 °C). Standard decontamination methods (1 M NaOH for 1 h or autoclaving at 134 °C for 18 min) reduced infectivity associated with the human-derived prion strain by less than 3 log10 LD50. In contrast, a 30 min treatment with the optimized enzymatic cleaning preparation protocols reduced infectivity by more than 3 log10 LD50 and when used in conjunction with autoclave cycles eliminated detectable levels of infectivity. The development of prion decontamination procedures that are compatible with routine cleaning and sterilization of medical and surgical instruments may reduce the risk of the transmission of prion disease in general surgery.

25 May 2022 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
LFLee J. Fairhead
Lee J. Fairhead
SSSimon Smith
Simon Smith
BSBeatrice Z. Sim
Beatrice Z. Sim
ASAlexandra Stewart
Alexandra Stewart
JSJames D. Stewart
James D. Stewart
JHJosh Hanson
Josh Hanson
An understanding of the seasonality of infections informs public health strategies and assists clinicians in their management of patients with undifferentiated illness. The seasonality of infections is driven by a variety of environmental and human factors; however, the role of individual climatic factors has garnered much attention. This study utilises Poisson regression models to assess the seasonality of six important infections in tropical Australia and their association with climatic factors and severe weather events over a 21-year period. Melioidosis and leptospirosis showed marked wet season predominance, while more cases of rickettsial disease and cryptococcosis were seen in cooler, drier months.Staphylococcus aureusinfections were not seasonal, while influenza demonstrated inter-seasonality. The climate did not significantly change during the 21 years of the study period, but the incidence of melioidosis and rickettsial disease increased considerably, highlighting the primacy of other factors—including societal inequality, and the impact of urban expansion—in the incidence of these infections. While anthropogenic climate change poses a threat to the region—and may influence the burden of these infections in the future—this study highlights the fact that, even for seasonal diseases, other factors presently have a greater effect on disease incidence. Public health strategies must also target these broader drivers of infection if they are to be effective.